This study evaluated a rapid biomineralization phenomenon exhibited by an osteoblastic cell line, UMR 106-01 BSP, when treated with either organic phosphates [beta-glycerophosphate (beta-GP), Ser-P, or Thr-P], inorganic phosphate (P-i), or calcium. In a dose-dependent manner, these agents (2-10 mM) stimulated confluent cultures to deposit mineral in the cell layer (ED(50) of similar to 4.6 mM for beta-GP (30 +/- 2 nmol Ca2+/mu g DNA) and similar to 3.8 mM (29 +/- 2 nmol Ca2+/mu g DNA) for P-i) with a plateau in mineral formation by 20 h (ET(50) approximate to 12-15 h). beta-GP or P-i treatment yielded mineral crystals having an x-ray diffraction pattern similar to normal human bone, Alizarin red-S histology demonstrated calcium mineral deposition in the extracellular matrix and what appeared to be intracellular paranuclear staining. Electron microscopy revealed small, needle-like crystals associated with fibrillar, extracellular matrix deposits and intracellular spherical structures. Mineral formation was inhibited by levamisole (ED(50) approximate to 250 mu M), pyrophosphate (ED(50) approximate to 1-10 mu M), actinomycin C-1 (500 ng/ml), cycloheximide (50 mu g/ml), or brefeldin A (1 mu g/ml). These results indicate that UMR 106-01 BSP cells form a bio apatitic mineralized matrix upon addition of supplemental phosphate. This process involves alkaline phosphatase activity, ongoing RNA and protein synthesis, as well as Golgi-mediated processing and secretion.